1. Silberstein SD. Topiramate in migraine prevention: A 2016 perspective. Headache 2017;57:165–78.
2. Dodick DW, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921–36.
3. Dodick DW. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications. Cephalalgia 2019;39:445–58.